Photo Late Stage Cancer Treatment Of Colorectal Cancer Oncology regarding Colorectal Cancer Clinical Trials
Article Related to Colorectal Cancer Clinical Trials :
Diagnose Colorectal Cancer or Colon Cancer – colorectal cancer clinical trials
Colorectal cancer, also known as CRC or colon cancer, is one of the leading cancers causing deaths in the U.S ., impressing both men and women evenly. Beating both prostate cancer and breast cancer in mortality rate, colon cancer is second to lung cancer in causing death. With roughly 150,000 new cases diagnosed per year and approximately 60,000 deaths per year, the singular fact is that colon cancer is very preventable. The fact is that when colon cancer is spied early, with treatment, the 5-year survival rate is more than 90%. This is why colon cancer screening is crucial to prevent and rapidly see this deadly disease.
Colon Cancer Screening
The American Cancer Society recommends that both men and women should adopt one of the following 5 colon cancer screening recommendations, even if they are only at average risk for developing colon cancer.
* A yearly fecal occult blood measure, likewise announced FOBT, or a fecal immunochemical assessment, also announced FIT
* A adaptable sigmoidoscopy test every 5 years
* A yearly fecal esoteric blood assessment( FOBT) or fecal immunochemical assessment( FIT) including a resilient sigmoidoscopy every 5 years
* A doubled comparison barium enema every 5 years
* A colonoscopy every 10 years
The most preferred option of all of these colon cancer screening recommendations is# 3: a yearly fecal occult blood measure( FOBT) or fecal immunochemical test( FIT) including a flexible sigmoidoscopy every 5 years. The American Cancer Society also recommends that all colon cancer screening tests with positive results be instantly followed by a colonoscopy.
A New Home Colon Cancer Screening Kit
One of the most exciting the development in colon cancer screening is the development of a brand-new dwelling research announced Quidel’s QuickVue iFOB Test. This easy test is a type of fecal immunochemical assessment( FIT) that individual patients exerts at home. In the privacy rights of dwelling, a patient collects a test, ends the contents of the equipment, and mails a sample to a specified physician or laboratory for researching. This simple home colon cancer screening measure sees any blood in the test, which indicates their own problems of gastrointestinal disorders like colon cancer.
Requiring exclusively one specimen, the Quidel QuickVue iFOB Test identifies human blood, or hemoglobin. Patients do not need to follow any dietary restraints, nonetheless, there are a few restraints considering drugs. This distinguishes this home colon cancer screening assessment from guaiac based research with arduous controls. The American Cancer Society recommends the Quidel QuickVue iFOB Test because it is patient friendly, arising in more people taking the test than with guaiac or FOBT measures. When the colon cancer screening process is simple, the hope is that more cases will make the test.
Unfortunately, even with the advancements in colon cancer screening, fewer than 50% of parties over persons under the age of 50 take the test on the recommended basis. Many parties over this age “ve never” even made a colon cancer screening test. Education shall respond. If parties knew that it could take 10 times for cancerous cadres to take over, they would realize that early sensing through a colon cancer screening is an easy and painless behavior to save their life